tiprankstipranks
Trending News
More News >
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Cash flow

Compare
1,099 Followers

Avidity Biosciences Cash Flow

RNA's free cash flow for Q3 2025 was $-160.06M. For the 2025 fiscal year, RNA's free cash flow was decreased by $-184.64M and operating cash flow was $-156.17M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -300.87M$ -119.06M$ -136.27M$ -94.81M$ -37.12M
Investing Cash Flow
$ -854.20M$ -130.07M$ -189.96M$ -82.52M$ -7.79M
Financing Cash Flow
$ 1.19B$ 93.86M$ 346.17M$ 176.32M$ 272.04M
End Cash Position
$ 222.66M$ 185.38M$ 340.65M$ 320.70M$ 321.71M
Free Cash Flow
$ -307.94M$ -123.29M$ -139.09M$ -98.55M$ -38.21M
Currency in USD

Avidity Biosciences Cash Flow